Literature DB >> 8627447

Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease.

T Matsubara1, W Mason, I A Kashani, M Kligerman, J C Burns.   

Abstract

Although gastrointestinal hemorrhage is a well-recognized complication of aspirin therapy, this side effect has not been previously reported in patients with Kawasaki disease (KD). We describe two children with typical KD who had massive gastrointestinal bleeding that required hospitalization and transfusion. Physicians caring for patients with KD should instruct parents on the signs and symptoms of aspirin toxicity. Fortunately, gastrointestinal hemorrhage appears to be a rare complication of salicylate therapy in patients with Kawasaki disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627447     DOI: 10.1016/s0022-3476(96)80140-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research.

Authors:  P A Brogan; A Bose; D Burgner; D Shingadia; R Tulloh; C Michie; N Klein; R Booy; M Levin; M J Dillon
Journal:  Arch Dis Child       Date:  2002-04       Impact factor: 3.791

Review 2.  Overview of pharmacological treatment of Kawasaki disease.

Authors:  Z Onouchi; T Kawasaki
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

Review 3.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  Hepatic dysfunction secondary to Kawasaki disease: characteristics, etiology and predictive role in coronary artery abnormalities.

Authors:  Goshgar Mammadov; Hui Hui Liu; Wei Xia Chen; Guo Zhen Fan; Rui Xue Li; Fei Fei Liu; Sama Samadli; Jing Jing Wang; Yang Fang Wu; Huang Huang Luo; Dong Dong Zhang; Wei Wei; Peng Hu
Journal:  Clin Exp Med       Date:  2019-11-16       Impact factor: 3.984

5.  Atypical Kawasaki disease and gastrointestinal manifestations.

Authors:  Ravinder Singh; Colin Ward; Mark Walton; Rabin Persad
Journal:  Paediatr Child Health       Date:  2007-03       Impact factor: 2.253

Review 6.  Salicylate for the treatment of Kawasaki disease in children.

Authors:  J H Baumer; S J L Love; A Gupta; L C Haines; I Maconochie; J S Dua
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

7.  Sensorineural hearing loss in patients with Kawasaki disease.

Authors:  Sun Young Park; Young Hyun Kim; Yeo Hyang Kim; Myung Chul Hyun; Young Hwan Lee
Journal:  Korean J Pediatr       Date:  2015-11-22

8.  The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS).

Authors:  Yasuyo Suzuki; Yasushi Enokido; Kenichiro Yamada; Mie Inaba; Kumiko Kuwata; Naoki Hanada; Tsuyoshi Morishita; Seiji Mizuno; Nobuaki Wakamatsu
Journal:  Oncotarget       Date:  2017-07-11

Review 9.  Frequently asked questions regarding treatment of Kawasaki disease.

Authors:  Jane C Burns
Journal:  Glob Cardiol Sci Pract       Date:  2017-10-31

10.  Is high-dose aspirin necessary in the acute phase of kawasaki disease?

Authors:  Goni Lee; Seung Eun Lee; Young Mi Hong; Sejung Sohn
Journal:  Korean Circ J       Date:  2013-03-31       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.